Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Influence of dialysis on the glucose profile in patients with diabetes: usefulness of continuous glucose monitoring.

Chantrel F, Sissoko H, Képénékian L, Smagala A, Meyer L, Imhoff O, Serb L, Fleury D, Dorey F, Krummel T, Le Floch JP, Kessler L.

Horm Metab Res. 2014 Oct;46(11):810-3. doi: 10.1055/s-0034-1370963. Epub 2014 Mar 13.

PMID:
24627097
2.

Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study.

Joubert M, Fourmy C, Henri P, Ficheux M, Lobbedez T, Reznik Y.

Diabetes Res Clin Pract. 2015 Mar;107(3):348-54. doi: 10.1016/j.diabres.2015.01.026. Epub 2015 Jan 21.

PMID:
25638452
3.

Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study.

Képénékian L, Smagala A, Meyer L, Imhoff O, Alenabi F, Serb L, Fleury D, Dorey F, Krummel T, Le Floch JP, Chantrel F, Kessler L.

Clin Nephrol. 2014 Oct;82(4):240-6. doi: 10.5414/CN108280.

PMID:
25161114
4.

Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes.

Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, Frankel AH, Tam FW, Dornhorst A, Frost G, Turner JJ.

Diabetes Care. 2009 Jul;32(7):1137-42. doi: 10.2337/dc08-1688. Epub 2009 Feb 5.

5.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
6.

Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.

Radermecker RP, Fayolle C, Brun JF, Bringer J, Renard E.

Diabetes Metab. 2013 May;39(3):258-62. doi: 10.1016/j.diabet.2012.12.004. Epub 2013 Mar 19.

7.

Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients.

Cosson E, Hamo-Tchatchouang E, Dufaitre-Patouraux L, Attali JR, Pariès J, Schaepelynck-Bélicar P.

Diabetes Metab. 2009 Sep;35(4):312-8. doi: 10.1016/j.diabet.2009.02.006. Epub 2009 Jun 26.

PMID:
19560388
8.

Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.

Jin SM, Kim TH, Bae JC, Hur KY, Lee MS, Lee MK, Kim JH.

Diabetes Res Clin Pract. 2014 May;104(2):266-72. doi: 10.1016/j.diabres.2014.02.003. Epub 2014 Feb 22.

PMID:
24630619
9.

Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.

Joubert M, Reznik Y.

Diabetes Res Clin Pract. 2012 Jun;96(3):294-305. doi: 10.1016/j.diabres.2011.12.010. Epub 2011 Dec 28. Review.

PMID:
22209014
10.

A comparison of internet monitoring with continuous glucose monitoring in insulin-requiring type 2 diabetes mellitus.

Tildesley HD, Wright AM, Chan JH, Mazanderani AB, Ross SA, Tildesley HG, Lee AM, Tang TS, White AS.

Can J Diabetes. 2013 Oct;37(5):305-8. doi: 10.1016/j.jcjd.2013.05.006.

PMID:
24500556
11.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
12.

Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.

Petrovski G, Dimitrovski C, Bogoev M, Milenkovic T, Ahmeti I, Bitovska I.

Diabetes Technol Ther. 2011 Nov;13(11):1109-13. doi: 10.1089/dia.2011.0081. Epub 2011 Jul 13.

PMID:
21751889
13.

Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

Rom J Intern Med. 2003;41(2):153-62.

PMID:
15526500
14.

Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring.

He YL, Foteinos G, Neelakantham S, Mattapalli D, Kulmatycki K, Forst T, Taylor A.

Diabetes Obes Metab. 2013 Dec;15(12):1111-9. doi: 10.1111/dom.12146. Epub 2013 Jul 14.

PMID:
23782529
15.

Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes.

Kohnert KD, Vogt L, Augstein P, Heinke P, Zander E, Peterson K, Freyse EJ, Salzsieder E.

Horm Metab Res. 2009 Feb;41(2):137-41. doi: 10.1055/s-0028-1128143. Epub 2009 Feb 12.

PMID:
19214924
17.

Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes.

Yoo HJ, An HG, Park SY, Ryu OH, Kim HY, Seo JA, Hong EG, Shin DH, Kim YH, Kim SG, Choi KM, Park IB, Yu JM, Baik SH.

Diabetes Res Clin Pract. 2008 Oct;82(1):73-9. doi: 10.1016/j.diabres.2008.06.015. Epub 2008 Aug 12.

PMID:
18701183
18.

Continuous glucose monitoring after kidney transplantation in non-diabetic patients: early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and graft failure.

Wojtusciszyn A, Mourad G, Bringer J, Renard E.

Diabetes Metab. 2013 Oct;39(5):404-10. doi: 10.1016/j.diabet.2012.10.007. Epub 2013 Aug 30.

PMID:
23999231
19.

Evaluation of daily glycemic profiles in well controlled children with type 1 diabetes mellitus using a continuous glucose monitoring system.

Tucholski K, Deja G, Skała-Zamorowska E, Jarosz-Chobot P.

Pediatr Endocrinol Diabetes Metab. 2009;15(1):29-33.

PMID:
19454186
20.

Supplemental Content

Support Center